21 Mar 2017 14:00
21 March 2017
RECKITT BENCKISER GROUP PLC
(The "Company" or "RB")
BOARD COMMITTEE CHANGES
The Company is pleased to announce the following changes to Board Committee membership.
On the recommendation of the Nomination Committee, on 20 March 2017 the Board approved the appointment of Mary Harris to its Remuneration Committee following the conclusion of the Company's Annual General Meeting, to be held on 4 May 2017 ("the 2017 AGM"). She will concurrently cease to be a member of the Audit Committee.
The Board further approved the appointment of Mary Harris to the position of Remuneration Committee Chair from 1 November 2017, when Judy Sprieser will step down. Judy will remain a Director of the Company and a member of the Remuneration Committee.
On the recommendation of the Nomination Committee, the Board further approved the appointment of André Lacroix to the position of Audit Committee Chair following the conclusion of the 2017 AGM, when Ken Hydon will step down. Ken will remain a Director of the Company and a member of the Audit Committee. André will continue to be the Senior Independent Director.
This disclosure is made in accordance with paragraph 9.6.11 of the Financial Conduct Authority's Listing rules.
For further Information:
Rupert BondyCompany Secretary+44 (0) 1753 217 800
Richard Joyce
SVP, Investor Relations, Communications & External Affairs
+44 (0)1753 217 800
103-105 Bath Road, Slough SL1 3UH
Registered in England and Wales, No. 6270876
Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108
About RB:
RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.
Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.
RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea.
For more information visit www.rb.com
*RB is the trading name of the Reckitt Benckiser group of companies